Integrated Drug Reviews at the US Food and Drug Administration

被引：2

作者：

Woodcock, Janet ^{[1
]}

Stein, Peter ^{[2
]}

Bugin, Kevin ^{[3
]}

机构：

[1] US FDA, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA

[2] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA

[3] US FDA, Special Programs, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA

来源：

关键词：

D O I：

10.1001/jamainternmed.2020.1981

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1248 / 1250

共 50 条

[1] Integrated Drug Reviews at the US Food and Drug Administration Reply
Doshi, Peter
Morten, Christopher J.
Herder, Matthew
[J]. JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1261 - 1262
[2] Integrated Drug Reviews at the US Food and Drug Administration-Legal Concerns and Knowledge Lost
Herder, Matthew
Morten, Christopher J.
Doshi, Peter
[J]. JAMA INTERNAL MEDICINE, 2020, 180 (05) : 629 - 630
[3] US food and drug administration
Goodman, Jesse
[J]. ONCOLOGY-NEW YORK, 2006, 20 (08): : 946 - 946
[4] US Food and Drug Administration
Blumenthal, G.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S37 - S37
[5] US Food and Drug Administration Updates
Sahin, L.
[J]. BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
[6] Independence at the US Food and Drug Administration
不详
[J]. LANCET, 2006, 367 (9523): : 1630 - 1630
[7] Urokinase and the US food and drug administration
Ouriel, K
[J]. JOURNAL OF VASCULAR SURGERY, 1999, 30 (05) : 957 - 958
[8] Transparency at the US Food and Drug Administration
Califf, Robert M.
[J]. JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
[9] US Food and Drug Administration and Design of Drug Approval Studies
Woloshin, Steven
Schwartz, Lisa M.
Frankel, Brittney
Faerber, Adrienne
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (20): : 2163 - 2165
[10] US Food and Drug Administration pushed to change
McCarthy, M
[J]. LANCET, 2006, 367 (9523): : 1643 - 1644